Measuring Response to Therapy by Near-Infrared Imaging of Tumors Using a Phosphatidylserine-Targeting Antibody Fragment
Imaging tumors and their response to treatment could be a valuable biomarker toward early assessment of therapy in patients with cancer. Phosphatidylserine (PS) is confined to the inner leaflet of the plasma membrane in normal cells but is externalized on tumor vascular endothelial cells (ECs) and t...
Main Authors: | Jian Gong, Richard Archer, Michael Brown, Seth Fisher, Connie Chang, Matthew Peacock, Christopher Hughes, Bruce Freimark |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2013-06-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2012.00039 |
Similar Items
-
Highly specific PET imaging of prostate tumors in mice with an iodine-124-labeled antibody fragment that targets phosphatidylserine.
by: Jason H Stafford, et al.
Published: (2013-01-01) -
Liposomal Encapsulation Enhances In Vivo Near Infrared Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model
by: Liang Zhang, et al.
Published: (2013-11-01) -
Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01) -
Antibody targeting of phosphatidylserine for detection and immunotherapy of cancer
by: Zohar DN, et al.
Published: (2018-06-01) -
Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome
by: Tatiana M. Reshetnyak, et al.
Published: (2022-06-01)